Augmedix Inc.

NASDAQ: AUGX · Real-Time Price · USD
2.35
0.00 (0.00%)
At close: Oct 01, 2024, 9:57 PM

Augmedix Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-19.17M -24.45M -17.85M
Depreciation & Amortization
1.1M 856K 691K
Stock-Based Compensation
2.47M 2.11M 1.39M
Other Working Capital
1.52M -874K 378K
Other Non-Cash Items
3.31M 3.83M 1.24M
Deferred Income Tax
-1.32M n/a -2.06M
Change in Working Capital
-1.82M 874K -2M
Operating Cash Flow
-15.44M -16.77M -18.59M
Capital Expenditures
-3.1M -1.41M -611K
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a
Investing Cash Flow
-3.1M -1.41M -611K
Debt Repayment
5M -1.13M 2.03M
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-365K -112K -4.21M
Financial Cash Flow
43.37M -1.24M 37.83M
Net Cash Flow
24.97M -19.6M 18.61M
Free Cash Flow
-18.55M -18.18M -19.2M